338 related articles for article (PubMed ID: 33725197)
1. Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma.
Zelin E; Zalaudek I; Agozzino M; Dianzani C; Dri A; Di Meo N; Giuffrida R; Marangi GF; Neagu N; Persichetti P; Toffoli L; Conforti C
Curr Treat Options Oncol; 2021 Mar; 22(4):35. PubMed ID: 33725197
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for Non-melanoma Skin Cancer.
Shalhout SZ; Emerick KS; Kaufman HL; Miller DM
Curr Oncol Rep; 2021 Aug; 23(11):125. PubMed ID: 34448958
[TBL] [Abstract][Full Text] [Related]
3. Investigative Landscape in Advanced Non-Melanoma Skin Cancers.
Reddy P; Yao M; Patel M
Curr Treat Options Oncol; 2021 Jun; 22(7):56. PubMed ID: 34097150
[TBL] [Abstract][Full Text] [Related]
4. Recent and Emerging Therapies for Cutaneous Squamous Cell Carcinomas of the Head and Neck.
Varra V; Smile TD; Geiger JL; Koyfman SA
Curr Treat Options Oncol; 2020 Apr; 21(5):37. PubMed ID: 32328817
[TBL] [Abstract][Full Text] [Related]
5. Sonic Hedgehog Pathway Inhibition in the Treatment of Advanced Basal Cell Carcinoma.
Leavitt E; Lask G; Martin S
Curr Treat Options Oncol; 2019 Nov; 20(11):84. PubMed ID: 31773379
[TBL] [Abstract][Full Text] [Related]
6. Where do we stand with immunotherapy for nonmelanoma skin cancers in the curative setting?
Alberti A; Gurizzan C; Baggi A; Bossi P
Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):89-95. PubMed ID: 37997885
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for Nonmelanoma Skin Cancer: Facts and Hopes.
Shalhout SZ; Kaufman HL; Emerick KS; Miller DM
Clin Cancer Res; 2022 Jun; 28(11):2211-2220. PubMed ID: 35121622
[TBL] [Abstract][Full Text] [Related]
8. Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence.
Stonesifer CJ; Djavid AR; Grimes JM; Khaleel AE; Soliman YS; Maisel-Campbell A; Garcia-Saleem TJ; Geskin LJ; Carvajal RD
Front Oncol; 2021; 11():734354. PubMed ID: 34988009
[TBL] [Abstract][Full Text] [Related]
9. Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer.
Rubatto M; Sciamarrelli N; Borriello S; Pala V; Mastorino L; Tonella L; Ribero S; Quaglino P
Front Med (Lausanne); 2022; 9():959289. PubMed ID: 36844955
[TBL] [Abstract][Full Text] [Related]
10. [Personalized medicine in the treatment of periocular tumors : Targeted treatment and use of immune checkpoint inhibitors].
Rokohl AC; Koch KR; Mor JM; Loreck N; Schlaak M; Mauch C; Bechrakis NE; Mohi A; Kakkassery V; Heindl LM
Ophthalmologe; 2020 Jun; 117(6):521-527. PubMed ID: 31938823
[TBL] [Abstract][Full Text] [Related]
11. Surgery in the Era of Immunotherapy for Advanced Head and Neck Non-melanoma Skin Cancer.
Lin A; Schmalbach CE
Curr Oncol Rep; 2023 Jul; 25(7):735-742. PubMed ID: 37010785
[TBL] [Abstract][Full Text] [Related]
12. Towards less mutilating treatments in patients with advanced non-melanoma skin cancers by earlier use of immune checkpoint inhibitors.
Hooiveld-Noeken JS; Eggen AC; Rácz E; de Vries EGE; Reyners AKL; Jalving M
Crit Rev Oncol Hematol; 2022 Dec; 180():103855. PubMed ID: 36257534
[TBL] [Abstract][Full Text] [Related]
13. Management of Skin Cancer in the High-Risk Patient.
Behan JW; Sutton A; Wysong A
Curr Treat Options Oncol; 2016 Dec; 17(12):60. PubMed ID: 27766546
[TBL] [Abstract][Full Text] [Related]
14. Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma.
Ascierto PA; Schadendorf D
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36455990
[TBL] [Abstract][Full Text] [Related]
15. Merkel Cell Carcinoma Therapeutic Update.
Cassler NM; Merrill D; Bichakjian CK; Brownell I
Curr Treat Options Oncol; 2016 Jul; 17(7):36. PubMed ID: 27262710
[TBL] [Abstract][Full Text] [Related]
16. Non-Surgical Therapeutic Strategies for Non-Melanoma Skin Cancers.
Zeng Q; Chen C; Chen D; Zhang G; Wang X
Curr Treat Options Oncol; 2023 Dec; 24(12):1978-1993. PubMed ID: 38095778
[TBL] [Abstract][Full Text] [Related]
17. Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response.
Zelin E; Maronese CA; Dri A; Toffoli L; Di Meo N; Nazzaro G; Zalaudek I
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743435
[TBL] [Abstract][Full Text] [Related]
18. Management of High-Risk Squamous Cell Carcinoma of the Skin.
Fu T; Aasi SZ; Hollmig ST
Curr Treat Options Oncol; 2016 Jul; 17(7):34. PubMed ID: 27262708
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
Pelster MS; Amaria RN
Curr Treat Options Oncol; 2020 Feb; 21(2):10. PubMed ID: 32025932
[TBL] [Abstract][Full Text] [Related]
20. How to Sequence Therapies in Mycosis Fungoides.
Brumfiel CM; Patel MH; Puri P; Besch-Stokes J; Lester S; Rule WG; Khera N; Sluzevich JC; DiCaudo DJ; Comfere N; Bennani NN; Rosenthal AC; Pittelkow MR; Mangold AR
Curr Treat Options Oncol; 2021 Sep; 22(11):101. PubMed ID: 34570278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
